Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death
New England Journal of Medicine - reports a mean increase in low-density lipoprotein (LDL) cholesterol of 18.6% among patients treated for 26 weeks with an 8-mg daily dose, as compared with placebo. 25 In observational studies and lipid-lowering trials, elevated levels of LDL cholesterol
PAHO Task Force Calls for “Trans Fat Free Americas”
Pan American Health Organization - Research has shown that trans fats contribute to heart disease by raising levels of “bad cholesterol” (low-density lipoprotein, or LDL), lowering levels of “good cholesterol” (high-density lipoprotein, or HDL), and damaging the cells in the linings